AZ has already made it clear its focus is on investing in the US market – which accounts for 30% of its sales – and started ...

AstraZeneca reported a significant 77% surge in quarterly net profit, reaching $2.53 billion, driven by strong US growth and ...

Across our pipeline we have announced an unprecedented 16 positive Phase III trials this year, with four since our previous results including high-impact readouts for baxdrostat in hypertension and ...

Baergic shareholders eligible to receive up to approximately $82 million in potential development, regulatory, and sales ...

British pharmaceutical giant AstraZeneca announced surging quarterly profit Thursday on strong sales of cancer drugs and as ...

Revenues and profits rose at British drug major AstraZeneca in the third quarter, with the firm reporting on Thursday that ...